caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1306912696

Yasmin Sahul

Family PracticeHarbor Beach, MII
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Yasmin Sahul's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 8 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
HARBOR BEACH COMMUNITY HOSPITAL INC34141
ST. JOSEPH MERCY PORT HURTON1314
BRONSON BATTLE CREEK HOSPITAL1130
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
HARBOR BEACH COMMUNITY HOSPITAL INC33129
MCLAREN PORT HURON2643
NORTIER, NOREEN2464
Laboratory Corporation Of America Holdings
Clinical Laboratory · Dublin, OH
2424
REGENTS OF THE UNIVERSITY OF MICHIGAN2223
BRONSON BATTLE CREEK HOSPITAL1535
ST. JOSEPH MERCY PORT HURTON1317
MCLAREN THUMB REGION1158
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
56
Beneficiaries
—
Total drug cost
$8K
Distinct drugs
4
Brand share
21.4%
Top prescribed drugs
Atorvastatin Calcium18 claims
Amlodipine Besylate15 claims
Apixaban12 claims
Lisinopril11 claims